This product contains Retatrutide (5mg), an experimental peptide currently being studied for its potential effects on metabolic health and weight management. Often referred to as a “triple agonist,” Retatrutide targets three key receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon.
Presented by SculptPeptides, this high-purity lyophilized powder is designed for laboratory settings. Each vial contains 5mg of the active compound, intended to provide researchers with a reliable subject for metabolic and biochemical analysis.
Key Features
-
Triple-Hormone Agonist: Targets GLP-1, GIP, and Glucagon receptors.
-
High Purity: Manufactured for consistent research results and stability.
-
Quantity: 5mg per vial.
-
Format: Lyophilized powder (requires reconstitution for use).
Disclaimer: This product is intended strictly for research and laboratory use only. It is not for human consumption, medical diagnosis, or therapeutic use. All research should be conducted by qualified professionals in a controlled environment.
